Todd Juan
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Oncology 12
- Colorectal Cancer Treatments and Studies 7
- HER2/EGFR in Cancer Research 3
- Co-authors
- Daniel J. Freeman (6 shared papers)Robert Radinsky (6 shared papers)Rafael G. Amado (3 shared papers)Sid Suggs (3 shared papers)Scott D. Patterson (4 shared papers)Michael Wolf (4 shared papers)Eric Van Cutsem (3 shared papers)Robert Sikorski (2 shared papers)
- Journals
- Blood (4 papers)Journal of Biological Chemistry (4 papers)Molecular and Cellular Biology (3 papers)Molecular Cancer Therapeutics (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Todd Juan
46 papers receiving 5.5k citations
Todd Juan's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 2.7k
- Cancer Research 812
- Hepatology 347
- Pathology and Forensic Medicine 746
- Sensory Systems 193
Countries citing papers authored by Todd Juan
This map shows the geographic impact of Todd Juan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Juan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Juan more than expected).
Fields of papers citing papers by Todd Juan
This network shows the impact of papers produced by Todd Juan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Juan. The network helps show where Todd Juan may publish in the future.
Co-authors
The 25 scholars most cited alongside Todd Juan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 2406 |
| 2 | 2008 | 364 | |
| 3 | 2000 | 322 | |
| 4 | 2007 | 258 | |
| 5 | 2009 | 257 | |
| 6 | 2010 | 190 | |
| 7 | 2011 | 184 | |
| 8 | 1995 | 148 | |
| 9 | Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. | 2003 | 142 |
| 10 | 2008 | 130 | |
| 11 | 1993 | 126 | |
| 12 | 1995 | 102 | |
| 13 | 1998 | 100 | |
| 14 | 2001 | 85 | |
| 15 | 2002 | 82 | |
| 16 | 1990 | 77 | |
| 17 | 2010 | 69 | |
| 18 | 1995 | 69 | |
| 19 | 1995 | 57 | |
| 20 | Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. | 1995 | 47 |
About Todd Juan
Todd Juan is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Surgery, having authored 47 papers that have together received 5.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Complement system in diseases (4 papers), Pancreatic function and diabetes (4 papers), Immune Response and Inflammation (4 papers), Glycosylation and Glycoproteins Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (812 citations), Hepatology (347 citations), Pathology and Forensic Medicine (746 citations) and Sensory Systems (193 citations). Todd Juan has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Daniel J. Freeman, Robert Radinsky, Rafael G. Amado, Sid Suggs, Scott D. Patterson, Michael Wolf, Eric Van Cutsem, Robert Sikorski, David Chang and Salvatore Siena. Their work appears in journals such as Blood, Journal of Biological Chemistry, Molecular and Cellular Biology, Molecular Cancer Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.